Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  GeneThera, Inc.    GTHR

 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
08/22/2017 09/15/2017 09/20/2017 10/10/2017 09/20/2017 Date
0.003(c) 0.003(c) 0.005139(c) 0(c) 0.005139 Last
63 400 18 000 3 000 1 3 000 Volume
+20.00% 0.00% +71.30% -100.00% +71.30% Change
More quotes
Company
GeneThera, Inc. is a biotechnology company.The company is focused on improving food safety by applying the molecular technologies to eradicate zoonotic diseases, such as Johne's, Mad Cow, Chronic Wasting, and E.coli disease.Its product candidate include Herd Guard, a management solution, which... 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on GENETHERA, INC.
2016 Genethera appoints scientific advisor
2016 Genethera secures new laboratory facilities to expand technology platforms
2015 Genethera, inc. issues comments on the first international research symposium..
2015 MYCOBACTERIUM AVIUM PARATUBERCULOSIS : The global warming of the cattle industry
2015 Genethera appoints two new members on its board of directors
2015 GeneThera Enters Into Exclusive Collaboration Agreement with Hudson Robotics ..
2008 GENETHERA INC COM USD0.002 : GeneThera Announces it is Set to Begin Commercial T..
2008 GENETHERA INC COM USD0.002 : GeneThera Releases Results From Initial Animal Test..
2008 GENETHERA INC COM USD0.002 : GeneThera - CHANGING DIRECTIONS - an Update to Shar..
2008 GENETHERA INC COM USD0.002 : STC.UNM Signs License Option Agreement With GeneThe..
More news
Sector news : Biotechnology & Medical Research - NEC
08:48aDJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
10/17DJJOHNSON & JOHNSON : Raises Guidance on Earnings Beat
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
More sector news : Biotechnology & Medical Research - NEC
Chart GENETHERA, INC.
Duration : Period :
GeneThera, Inc. Technical Analysis Chart | GTHR | US37185E3062 | 4-Traders
Managers
NameTitle
Antonio Milici Chairman, President & Chief Executive Officer
Tannya L. Irizarry Chief Financial & Administrative Officer
Bruce Winslett Director
Sector and Competitors
1st jan.Capitalization (M$)
GENETHERA, INC.-65.74%0
INCYTE CORPORATION14.00%24 360
QUINTILES IMS HOLDINGS INC31.30%21 440
CELLTRION, INC.--.--%20 806
LONZA GROUP64.29%19 850
ALNYLAM PHARMACEUTICALS, INC.228.53%10 889